313490-25-4 Usage
Uses
Used in Pharmaceutical Synthesis:
TERT-BUTOXYCARBONYLAMINO-(2-CHLORO-PHENYL)-ACETIC ACID is used as a key intermediate in the synthesis of pharmaceuticals and other organic compounds. Its unique chemical structure allows it to be a versatile building block for creating new drugs with potential therapeutic benefits.
Used in Prodrug Development:
In the pharmaceutical industry, TERT-BUTOXYCARBONYLAMINO-(2-CHLORO-PHENYL)-ACETIC ACID is used as a prodrug candidate. Its ability to be metabolized in the body to produce the active form of a drug makes it a valuable asset in drug development, potentially leading to improved drug delivery and efficacy.
Used in Enzyme Inhibition Research:
TERT-BUTOXYCARBONYLAMINO-(2-CHLORO-PHENYL)-ACETIC ACID is used as an enzyme inhibitor in research settings. Its capacity to inhibit certain enzymes has been studied for its potential use in treating various medical conditions, making it a promising compound for further investigation in the development of new therapeutic agents.
Used in Medical Condition Treatment:
Although still under research, TERT-BUTOXYCARBONYLAMINO-(2-CHLORO-PHENYL)-ACETIC ACID is being explored for its potential use in treating various medical conditions. Its therapeutic applications are of interest to the pharmaceutical industry, as it may contribute to the development of novel treatments and therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 313490-25-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,3,4,9 and 0 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 313490-25:
(8*3)+(7*1)+(6*3)+(5*4)+(4*9)+(3*0)+(2*2)+(1*5)=114
114 % 10 = 4
So 313490-25-4 is a valid CAS Registry Number.
InChI:InChI=1/C13H16ClNO4/c1-13(2,3)19-12(18)15-10(11(16)17)8-6-4-5-7-9(8)14/h4-7,10H,1-3H3,(H,15,18)(H,16,17)
313490-25-4Relevant academic research and scientific papers
Ferraboschi, Patrizia,Mieri, Maria De,Galimberti, Fiorella
, p. 2136 - 2141 (2010)
The (S)-2-chlorophenylglycine moiety is well recognized in the structure of (S)-clopidogrel, a known antithrombotic drug. We prepared an enantiomerically pure chiral building block via an enzyme-catalyzed resolution of (RS)-N-Boc-2-chlorophenylglycine methylester. The best results were obtained by means of an immobilized subtilisin, the cross-linked enzyme aggregate (Alcalase-CLEA). The high enantiomeric excess of the synthon obtained remained the same over the course of clopidogrel synthesis; the simplicity of the process makes this pathway suitable for large-scale preparation.
